Position
Squarepoint Ops LLC in Supernus Pharmaceuticals, Inc.
Back to the book · All holders of SUPN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $50.8K$49.70 → $51.69
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 92.4K | $4.59M | — | — | — | 0.0% |
| Q1 2026 | 25.5K | $1.32M | $51.69 | $50.8K | −$3.33M | 0.0% |